BRESCIA, CLAUDIO
BRESCIA, CLAUDIO
Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study
2024 Megna, Matteo; Ruggiero, Angelo; Tommasino, Nello; Brescia, Claudio; Martora, Fabrizio; Cacciapuoti, Sara; Potestio, Luca
The impact of body mass index on dupilumab treatment outcomes in adult atopic dermatitis patients
2024 Patruno, Cataldo; Potestio, Luca; Cecere, Daniele; Cosenza, Andrea; Brescia, Claudio; Napolitano, Maddalena
Tralokinumab for the Treatment of Adult Atopic Dermatitis in Special Populations
2024 Potestio, Luca; Patruno, Cataldo; Dastoli, Stefano; Brescia, Claudio; Napolitano, Maddalena
The efficacy of dupilumab in patients affected by atopic dermatitis who previously failed tralokinumab
2024 Potestio, L.; Brescia, C.; Patruno, C.; Napolitano, M.
Indirect Comparison Between Bimekizumab and Brodalumab for the Management of Moderate to Severe Psoriasis: A 36-Week Real-Life Study
2025 Potestio, Luca; Martora, Fabrizio; Raia, Flavia; Lucagnano, Gioacchino; Brescia, Claudio; Torta, Ginevra; Megna, Matteo
Hidradenitis Suppurativa in Elderly Patients: Clinical and Therapeutical Outcomes—A Review of the Literature
2024 Martora, Fabrizio; Tommasino, Nello; Brescia, Claudio; Potestio, Luca; Battista, Teresa; Megna, Matteo
Allergic Contact Dermatitis From a Polyester Trouser Mimicking Atopic Dermatitis
2025 Brescia, C.; Potestio, L.; di Vico, F.; Patruno, C.; Napolitano, M.
Efficacy and safety of JAK inhibitors in patients aged > 60 years with moderate-to-severe atopic dermatitis: a 52-week multicenter, real-life study—IL AD (Italian Landscape Atopic Dermatitis)
2025 Potestio, L.; Patruno, C.; Narcisi, A.; Costanzo, A.; Ibba, L.; Gargiulo, L.; Malagoli, P.; Ortoncelli, M.; Ribero, S.; Mastorino, L.; Leo, F.; Ferrucci, S. M.; Angileri, L.; Barei, F.; Stingeni, L.; Hansel, K.; Sciarrone, C.; Girolomoni, G.; Maurelli, M.; Foti, C.; Tirone, B.; Balato, A.; Esposito, M.; Paolino, G.; Mercuri, S. R.; Pezzolo, E.; Savoia, P.; Brescia, C.; Napolitano, M.
Biologics targeting IL-23 in moderate-to-severe psoriasis: lessons learned from real-world use
2025 Megna, Matteo; Lauletta, Giuseppe; D'Agostino, Michela; Tommasino, Nello; Salsano, Antonia; Noto, Matteo; Brescia, Claudio; Foggia, Luciano; Scaramuzzino, Lorenzo; Potestio, Luca
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study | 1.1 Articolo in rivista | 2024 | Megna, Matteo; Ruggiero, Angelo; Tommasino, Nello; Brescia, Claudio; Martora, Fabrizio; Cacciapuoti, Sara; Potestio, Luca | |
| The impact of body mass index on dupilumab treatment outcomes in adult atopic dermatitis patients | 1.1 Articolo in rivista | 2024 | Patruno, Cataldo; Potestio, Luca; Cecere, Daniele; Cosenza, Andrea; Brescia, Claudio; Napolitano, Maddalena | |
| Tralokinumab for the Treatment of Adult Atopic Dermatitis in Special Populations | 1.1 Articolo in rivista | 2024 | Potestio, Luca; Patruno, Cataldo; Dastoli, Stefano; Brescia, Claudio; Napolitano, Maddalena | |
| The efficacy of dupilumab in patients affected by atopic dermatitis who previously failed tralokinumab | 1.1 Articolo in rivista | 2024 | Potestio, L.; Brescia, C.; Patruno, C.; Napolitano, M. | |
| Indirect Comparison Between Bimekizumab and Brodalumab for the Management of Moderate to Severe Psoriasis: A 36-Week Real-Life Study | 1.1 Articolo in rivista | 2025 | Potestio, Luca; Martora, Fabrizio; Raia, Flavia; Lucagnano, Gioacchino; Brescia, Claudio; Torta, Ginevra; Megna, Matteo | |
| Hidradenitis Suppurativa in Elderly Patients: Clinical and Therapeutical Outcomes—A Review of the Literature | 1.8 Articolo in rassegna (review) | 2024 | Martora, Fabrizio; Tommasino, Nello; Brescia, Claudio; Potestio, Luca; Battista, Teresa; Megna, Matteo | |
| Allergic Contact Dermatitis From a Polyester Trouser Mimicking Atopic Dermatitis | 1.1 Articolo in rivista | 2025 | Brescia, C.; Potestio, L.; di Vico, F.; Patruno, C.; Napolitano, M. | |
| Efficacy and safety of JAK inhibitors in patients aged > 60 years with moderate-to-severe atopic dermatitis: a 52-week multicenter, real-life study—IL AD (Italian Landscape Atopic Dermatitis) | 1.1 Articolo in rivista | 2025 | Potestio, L.; Patruno, C.; Narcisi, A.; Costanzo, A.; Ibba, L.; Gargiulo, L.; Malagoli, P.; Ortoncelli, M.; Ribero, S.; Mastorino, L.; Leo, F.; Ferrucci, S. M.; Angileri, L.; Barei, F.; Stingeni, L.; Hansel, K.; Sciarrone, C.; Girolomoni, G.; Maurelli, M.; Foti, C.; Tirone, B.; Balato, A.; Esposito, M.; Paolino, G.; Mercuri, S. R.; Pezzolo, E.; Savoia, P.; Brescia, C.; Napolitano, M. | |
| Biologics targeting IL-23 in moderate-to-severe psoriasis: lessons learned from real-world use | 1.1 Articolo in rivista | 2025 | Megna, Matteo; Lauletta, Giuseppe; D'Agostino, Michela; Tommasino, Nello; Salsano, Antonia; Noto, Matteo; Brescia, Claudio; Foggia, Luciano; Scaramuzzino, Lorenzo; Potestio, Luca |